Lingti Kong

13PUBLICATIONS
15CO-AUTHORS
Characterisation of biological macromoleculesGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 29, 2026
Differential signal strength of male sexual dysfunction associated with antidepressants: a disproportionality analysis of FAERS database.

|Jan 10, 2026
Pharmacovigilance study and development of a clinical decision flowchart for personalized selection of trastuzumab, T-DXd, and T-DM1 in breast cancer patients.

Xiaohu Yang, Xiaomei Pei, Chunli Song

|Dec 13, 2024
Optimizing the dosing regimens of linezolid against gram-positive cocci in critically ill patients with different renal functions: a Monte Carlo simulation.

Hongyu Qiu, Hao Li, Lingti Kong

|Jul 09, 2024
Development and validation of a clinical risk score nomogram for predicting voriconazole trough concentration above 5 mg/L: a retrospective cohort study.

Mengyuan Xie, Manxue Jiang, Jian Xu

|Apr 21, 2023
Optimization of Voriconazole Dosing Regimens Against Aspergillus Species and Candida Species in Pediatric Patients After Hematopoietic Cell Transplantation: A Theoretical Study Based on Pharmacokinetic/Pharmacodynamic Analysis.

Mengyuan Xie, Manxue Jiang, Hongyu Qiu

|Jan 26, 2023
A post-marketing pharmacovigilance study of avapritinib: Adverse event data mining and analysis based on the United States Food and Drug Administration Adverse Event Reporting System database.

Li Rong, Mengyuan Xie, Manxue Jiang

Pageof 3

Frequent Collaborators

1 joint publications

Linhu Ye

1 joint publications

Lei Cheng

1 joint publications

Xinqian Zhao

1 joint publications

Guoyan Xie